114 Role of Vaccine-induced V2 Antibodies in Protection From HIV Infection of Recipients in the RV144 Clinical Vaccine Trial
Publication
, Conference
Zolla-Pazner, S; Williams, C; deCamp, A; Morris, D; Haynes, B; Kim, J; Michael, N; Rao, M
Published in: JAIDS Journal of Acquired Immune Deficiency Syndromes
April 2012
Duke Scholars
Published In
JAIDS Journal of Acquired Immune Deficiency Syndromes
DOI
ISSN
1525-4135
Publication Date
April 2012
Volume
59
Issue
Supplement 1
Start / End Page
46 / 46
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related Subject Headings
- Virology
- 4206 Public health
- 4202 Epidemiology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Zolla-Pazner, S., Williams, C., deCamp, A., Morris, D., Haynes, B., Kim, J., … Rao, M. (2012). 114 Role of Vaccine-induced V2 Antibodies in Protection From HIV Infection of Recipients in the RV144 Clinical Vaccine Trial. In JAIDS Journal of Acquired Immune Deficiency Syndromes (Vol. 59, pp. 46–46). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/01.qai.0000413733.06987.08
Zolla-Pazner, Susan, Constance Williams, Allan deCamp, Daryl Morris, Barton Haynes, Jerome Kim, Nelson Michael, and Mangala Rao. “114 Role of Vaccine-induced V2 Antibodies in Protection From HIV Infection of Recipients in the RV144 Clinical Vaccine Trial.” In JAIDS Journal of Acquired Immune Deficiency Syndromes, 59:46–46. Ovid Technologies (Wolters Kluwer Health), 2012. https://doi.org/10.1097/01.qai.0000413733.06987.08.
Zolla-Pazner S, Williams C, deCamp A, Morris D, Haynes B, Kim J, et al. 114 Role of Vaccine-induced V2 Antibodies in Protection From HIV Infection of Recipients in the RV144 Clinical Vaccine Trial. In: JAIDS Journal of Acquired Immune Deficiency Syndromes. Ovid Technologies (Wolters Kluwer Health); 2012. p. 46–46.
Zolla-Pazner, Susan, et al. “114 Role of Vaccine-induced V2 Antibodies in Protection From HIV Infection of Recipients in the RV144 Clinical Vaccine Trial.” JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 59, no. Supplement 1, Ovid Technologies (Wolters Kluwer Health), 2012, pp. 46–46. Crossref, doi:10.1097/01.qai.0000413733.06987.08.
Zolla-Pazner S, Williams C, deCamp A, Morris D, Haynes B, Kim J, Michael N, Rao M. 114 Role of Vaccine-induced V2 Antibodies in Protection From HIV Infection of Recipients in the RV144 Clinical Vaccine Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. Ovid Technologies (Wolters Kluwer Health); 2012. p. 46–46.
Published In
JAIDS Journal of Acquired Immune Deficiency Syndromes
DOI
ISSN
1525-4135
Publication Date
April 2012
Volume
59
Issue
Supplement 1
Start / End Page
46 / 46
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related Subject Headings
- Virology
- 4206 Public health
- 4202 Epidemiology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences